Krsnaa Diagnostics Ltd.
Snapshot View

420.65 +0.65 ▲0.2%

31 January 2023, 09:39:56 AM
Volume: 3,640

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.krsnaadiagnostics.com
Market Cap 1,317.13 Cr.
Enterprise Value(EV) 1,190.76 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 20.33 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 20.61 Trailing Twelve Months Ending 2022-09
Industry PE 46.72 Trailing Twelve Months Ending 2022-09
Book Value / Share 224.88 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.86 Calculated using Price: 419.00
Dividend Yield 0.60 Period Ending 2022-03
No. of Shares Subscribed 3.14 Cr. 31,397,613 Shares
FaceValue 5
Company Profile
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.15%
1 Week
-0.64%
1 Month
-8.73%
3 Month
-11.10%
6 Month
-24.04%
1 Year
-36.14%
2 Year
5 Year
10 Year
1 years 2022-03
Return on Equity (%) 10.02
Return on Capital Employed (%) 14.47
Return on Assets (%) 7.81

Balance Sheet View Details >>

Particulars 2 years 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 684 706
Non Curr. Liab. 42 40
Curr. Liab. 149 176
Minority Int.
Equity & Liab. 875 922
Non Curr. Assets 541 591
Curr. Assets 334 332
Misc. Exp. not W/O
Total Assets 875 922

Profit Loss View Details >>

Particulars 2 years 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 455 451
Other Income 15 17
Total Income 470 468
Total Expenditure -324 -334
PBIDT 146 134
Interest -18 -7
Depreciation -41 -46
Taxation -18 -16
Exceptional Items
PAT 68 64
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 68 64
Adjusted EPS 22 20

Cash Flow View Details >>

Particulars 1 years 2022-03 Rs. Cr.
Cash Fr. Operatn. 128
Cash Fr. Inv. -241
Cash Fr. Finan. 176
Net Change 64
Cash & Cash Eqvt 88

Shareholding Pattern View Details >>

6 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 27.38 27.38 27.38 27.38 27.80 27.80
Public 72.62 72.62 72.62 72.62 72.20 72.20
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 30 Jan 2023
Updates
Krsnaa Diagnostics Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 -Winning of Tender.'.
Wed, 25 Jan 2023
Updates
Krsnaa Diagnostics Limited has informed the Exchange regarding 'Commencement ofOperations.'.
Tue, 24 Jan 2023
Updates
Krsnaa Diagnostics Limited has informed the Exchange regarding 'Commencement ofOperations.'.

Technical Scans View Details >>

Mon, 30 Jan 2023
Higher Trade Quantity Higher Trade Quantity
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,036.05 -1.5%
Divi's Laboratories Ltd. 89,367.34 3,334.70 -0.9%
Cipla Ltd. 83,741.18 1,016.85 -1.7%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,336.65 +0.2%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,157.35 -1.9%
Torrent Pharmaceuticals Ltd. 52,291.51 1,541.65 -0.4%
Abbott India Ltd. 44,555.01 21,045.00 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,036.05 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,334.70 -0.9%
Cipla Ltd. Consolidated 2022-12 31.74 1,016.85 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,336.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,157.35 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,541.65 -0.4%
Abbott India Ltd. Standalone 2022-09 50.53 21,045.00 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,036.05 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,334.70 -0.9%
Cipla Ltd. Consolidated 2022-12 3.69 1,016.85 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,336.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,157.35 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,541.65 -0.4%
Abbott India Ltd. Standalone 2022-09 16.41 21,045.00 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,036.05 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,334.70 -0.9%
Cipla Ltd. Consolidated 2022-03 0.04 1,016.85 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,336.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,157.35 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.65 -0.4%
Abbott India Ltd. Standalone 2022-03 0.00 21,045.00 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,036.05 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,334.70 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 1,016.85 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,336.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,157.35 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.65 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 21,045.00 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,036.05 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,334.70 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 1,016.85 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,336.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,157.35 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.65 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 21,045.00 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,036.05 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,334.70 -0.9%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,016.85 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,336.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,157.35 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.65 -0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,045.00 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,036.05 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,334.70 -0.9%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,016.85 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,336.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,157.35 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.65 -0.4%
Abbott India Ltd. Standalone 2022-03 798.70 21,045.00 +0.3%

FAQ's On Krsnaa Diagnostics Ltd.

What is Krsnaa Diagnostics share price?

Can I buy Krsnaa Diagnostics shares now?

What is the Dividend Yield of Krsnaa Diagnostics?

What is the Market Cap of Krsnaa Diagnostics?

What are the key metrics to analyse Krsnaa Diagnostics?

What is the 52 Week High and Low of Krsnaa Diagnostics?

What is the trend of Krsnaa Diagnostics share price?